Large Volume Wearable Injectors Market, 2030 Dublin, Jan.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
24
Large Volume Wearable Injectors Market, 2030

Dublin, Jan. 31, 2019 (GLOBE NEWSWIRE) -- The "Large Volume Wearable Injectors Market (4th Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering.

The report features an extensive study of the current market landscape and the likely future evolution of self-injection devices, over the next twelve years. It specifically lays emphasis on the emergence of patient-centric, convenient, cost-effective and user-friendly wearable drug delivery solutions that are capable of administering large volumes of a drug subcutaneously, in the home-care setting.

One of the key objectives of the report was to estimate the existing market size and potential future growth opportunities for large volume wearable injectors. Based on parameters, such as the number of commercialized devices, number of devices under development, the price of the device and the annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the period 2018-2030. The report also features sales forecasts for the overall large volume wearable injectors market with a detailed market segmentation on the therapeutic area, geographical distribution of the market (North America / Europe / Asia Pacific / RoW), type of device (patch pump / injector and infusion pump / injector) and usability (reusable / disposable). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios namely the conservative, base, and optimistic scenarios, which represent different tracks of the industry's evolution. Key Topics Covered:

1. Preface 1.1. Scope of the Report 1.2. Research Methodology 1.3. Chapter Outlines 2. Executive Summary 3. Introduction 3.1. Chapter Overview 3.2. An Overview of Drug Delivery Devices 3.3. Conventional Parenteral Delivery 3.3.1 Needlestick Injuries 3.3.1.1. Incidence and Cost Burden 3.3.1.2. Prevention of Needlestick Injuries 3.3.1.3. Government Legislations for the Prevention of Needlestick Injuries 3.4. Emergence of Self-Administration Devices 3.4.1. Driving Factors 3.4.1.1. Rising Burden of Chronic Diseases 3.4.1.2. Healthcare Cost Savings 3.4.1.3. Need for Immediate Treatment in Emergency Situations 3.4.1.4. Growing Injectable Drugs Market 3.4.1.5. Rising Focus on Patient Centricity 3.4.1.6. Need for Improving Medication Adherence 3.5. Available Self-Injection Devices 3.5.1. Prefilled Syringes 3.5.2. Pen-Injectors 3.5.3. Autoinjectors 3.5.4. Needle-Free Injectors 3.5.5. Large Volume Wearable Injectors 3.6. Regulatory Considerations 3.6.1. Medical Devices 3.6.2. Drug Device Combinations 3.7. Future Perspectives 4. Large Volume Wearable Injectors: Current Market Landscape 4.1. Chapter Overview 4.2. Large Volume Wearable Injectors: Overall Market Landscape 4.2.1. Large Volume Wearable Injectors for Non-Insulin Drugs: Market Landscape 4.2.2. Large Volume Drug Device Combinations: Market Landscape 4.2.3. Large Volume Wearable Injectors for Non-Insulin Drugs: Analysis of Developers (Devices and Drug Device Combinations) 4.2.4. Large Volume Wearable Injectors for Insulin: Market Landscape 4.2.5. Large Volume Wearable Injectors for Insulin: Analysis of Developers 5. Product Competitiveness Analysis 5.1. Chapter Overview 5.2. Methodology 5.3. Product Competitiveness Analysis 5.3.1. Large Volume Wearable Injectors for Non-Insulin Drugs 5.3.2. Large Volume Drug Device Combinations 5.3.3. Large Volume Wearable Injectors for Insulin 6. Large Volume Wearable Injectors: Key Players 6.1. Chapter Overview 6.2. Large Volume Wearable Injectors for Non-Insulin Drugs: Key Players 6.2.1. Becton Dickinson 6.2.2. Bespak 6.2.3. Insulet 6.2.4. Medtronic 6.2.5. Roche 6.2.6. Sonceboz 6.2.7. Enable Injections 6.2.8. Sensile Medical 6.2.9. SteadyMed Therapeutics 6.2.10. West Pharmaceutical Services 6.2.11. Weibel CDS 6.3.1. CellNovo 6.3.2. CeQur 6.3.3. Debiotech 6.3.4. Eli Lilly 6.3.5. PharmaSens 6.3.6. SOOIL 6.3.7. Tandem Diabetes Care 7. Drug-Device Combinations: Tabulated Profiles 7.1. Chapter Overview 7.2. Apomorphine / ND0701 7.3. Bupivacaine / SMT-301 7.4. Ceftriaxone / sc2Wear Infusor 7.5. Furosemide / sc2Wear Infusor 7.6. Herceptin / Single Use Injector 7.7. Ketorolac / SMT-201 7.8. Levadopa and Carbidopa / ND0612 and ND0901 7.9. Neulasta / Omnipod 7.10. Repatha / Pushtronex System 7.11. Treprostinil / Trevyent 8. Patent Analysis 8.1. Chapter Overview 8.2. Scope and Methodology 8.3. Large Volume Wearable Injectors: Patent Analysis 8.3.1. Analysis by Publication Year 8.3.2. Analysis by Patent Offices Involved 8.3.3. Analysis by CPC Classification 8.3.4. Emerging Areas 8.3.5. Leading Players Based on Number of Patents 8.4. Large Volume Wearable Injectors: Patent Benchmarking Analysis 8.4.1. Analysis by Patent Characteristics 8.4.2. Analysis by Geography 8.5. Large Volume Wearable Injectors: Patent Valuation Analysis 9. Emerging Trends On Social Media 9.1. Chapter Overview 9.2. Large Volume Wearable Injectors: Trends on Twitter 9.2.1. Historical Trend in Volume of Tweets 9.2.2. Trending Words / Phrases Related to Large Volume Wearable Injectors 9.2.3. Most Influential Authors 9.2.4. Popular Players on Twitter 9.2.4.1. Roche (Accu-Chek Solo Micropump System) 9.2.4.2. Cellnovo (Cellnovo Insulin Pump) 9.2.4.3. Insulet (Omnipod) 9.2.4.4. Medtronic (Minimed Wearable Injectors) 9.2.4.5. Comparison of Popular Players Based on Number of Tweets 9.3. Concluding Remarks 10. Clinical Trial Analysis 10.1. Chapter Overview 10.2. Scope and Methodology 10.3. Large Volume Wearable Injectors: Clinical Trial Analysis 11. Case Study: Role of CMOS in Device Development Supply Chain 11.1. Chapter Overview 11.2. Device Development Supply Chain 11.3. Significance of CMOs in the Drug Delivery Device Development Process 11.4. List of Contract Manufacturing Organizations 11.4.1. Contract Manufacturers: Geographical Distribution and Services Offered 12. Large Volume Wearable Injectors: Likely Drug Candidates 12.1. Chapter Overview 12.2. Marketed Drugs 12.2.1. Most Likely Candidates for Delivery via Large Volume Wearable Injectors 12.2.2. Likely Candidates for Delivery via Large Volume Wearable Injectors 12.2.3. Less Likely Candidates for Delivery via Large Volume Wearable Injectors 12.2.4. Unlikely Candidates for Delivery via Large Volume Wearable Injectors 12.3. Clinical Drug Candidates 12.3.1. Biologics 12.3.2. Small Molecules 13. Market Sizing and Opportunity Analysis 13.1. Chapter Overview 13.2. Forecast Methodology and Key Assumptions 14. Future Growth Opportunities 14.1. Chapter Overview 14.2. SWOT Analysis 14.2.1. Strengths 14.2.2. Weaknesses 14.2.3. Opportunities 14.2.4. Threats 14.3. Future Growth Opportunities 15. Executive Insights: Interview Transcripts & Company Snapshot 15.1. Chapter Overview 15.2. Elcam Medical 15.3. Enable Injections 15.4. Medipacs 15.5. Ratio Drug Delivery 15.6. scPharmaceuticals 15.7. Sorrel Medical 15.8. Subcuject 15.9. West Pharmaceutical Services

Companies Mentioned

  • 3M
  • Abbott
  • AbbVie
  • AbGenomics
  • Ablynx
  • Acceleron Pharma
  • Actavis Pharma
  • ADC Therapeutics
  • Adrenomed
  • Aduro BioTech
  • Advaxis
  • Aeglea BioTherapeutics
  • Affibody
  • Affimed
  • Agenus
  • AgonOx
  • Akesobio Australia
  • Alder BioPharmaceuticals
  • Alector
  • Alexion Pharmaceuticals
  • Alkahest
  • Alkermes
  • Allakos
  • Allergan
  • Allozyne
  • Alnylam Pharmaceuticals
  • AlphaCore Pharma
  • Altor BioScience
  • Ambrx
  • amcure
  • Amgen
  • Amicus Therapeutics
  • Amphivena Therapeutics
  • Amplyx Pharmaceuticals
  • Amylin Pharmaceuticals
  • Angiochem
  • Animas
  • Antares Pharma
  • Antaros Medical
  • Aprea Therapeutics
  • Aptevo Therapeutics
  • argenx
  • Argos Therapeutics
  • ArmaGen
  • ARMO BioSciences
  • Aronora
  • Asklepion Pharmaceuticals
  • Astellas Pharma
  • AstraZeneca
  • Atridia
  • AVEO Pharmaceuticals
  • Axon Neuroscience
  • Bang & Olufsen Medicom
  • Baril
  • Basilea Pharmaceutica
  • Battelle
  • Baxter International
  • Bayer
  • Bayhill Therapeutics
  • Becton Dickinson
  • BeiGene
  • Beijing Dongfang Biotech
  • Bespak
  • Bio-Path Holdings
  • Bio-Thera Solutions
  • BioArctic
  • BIOCAD
  • bioCSL
  • Biogen
  • BioIntegrator
  • Bioject Medical Technologies
  • BioMarin Pharmaceutical
  • Bioniz Therapeutics
  • BioNTech
  • Biotest Pharmaceuticals
  • Boehringer Ingelheim
  • Boston Pharmaceuticals
  • Bristol Myers Squibb
  • Calando Pharmaceuticals
  • Calibra Medical
  • CANbridge Life Sciences
  • Cancer Advances
  • Cara Therapeutics
  • Catalyst Biosciences
  • CEL-SCI
  • Celgene
  • Celldex Therapeutics
  • Cellnovo
  • CeQur
  • Chimerix
  • CHO Pharma
  • Chugai Pharmaceutical
  • Cidara Therapeutics
  • Cleveland BioLabs
  • Conjupro Biotherapeutics
  • ContraFect
  • Cour Pharmaceutical Development
  • CSL Behring
  • CSPC Pharmaceutical Group
  • CStone Pharmaceuticals
  • CureTech
  • CytoDyn
  • Daikyo Seiko
  • Datwyler
  • Debiotech
  • DEKA
  • Dekkun
  • Delta-Fly Pharma
  • Dendreon
  • Dexcom
  • DiaMedica Therapeutics
  • Diamyd Medical
  • E3D Elcam Drug Delivery Devices
  • EG-GILERO
  • Eisai
  • Eli Lilly
  • Elusys Therapeutics
  • EMD Serono
  • Emergent BioSolutions
  • Enable Injections
  • Endo Pharmaceuticals
  • Endocyte
  • EnGeneIC
  • EOFlow
  • EpicentRx
  • Eternity Healthcare
  • European Pharma Group
  • F2G
  • Fabrico
  • FibroGen
  • Finox Biotech
  • Five Prime Therapeutics
  • Flex Pharma
  • Flowonix Medical
  • Galaxy Biotech
  • Galena Biopharma
  • Genentech
  • GENERON
  • GeneScience Pharmaceuticals
  • Genexine
  • Genzyme
  • Gerresheimer
  • Gilead Sciences
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Gliknik
  • Guangzhou Cellprotek Pharmaceutical
  • HAL Allergy
  • Halozyme Therapeutics
  • Hanmi Pharmaceutical
  • Haselmeier
  • Helsinn Healthcare
  • Hemispherx Biopharm
  • Hoffmann-La Roche
  • Huabo Biopharm
  • ImClone Systems
  • Immatics Biotechnologies
  • Immune Response BioPharma
  • ImmuneMed
  • ImmunGene
  • Immunocore
  • ImmunoFrontier
  • ImmunoGen
  • Immunomedics
  • Immunotope
  • Immunovaccine
  • Implicit Bioscience
  • Incuron
  • Incyte
  • Injex Pharma
  • Innate Pharma
  • Innovent Biologics
  • Inovio Pharmaceuticals
  • Insulet
  • iNtRON Biotechnology
  • IO Biotech
  • Ionis Pharmaceuticals
  • Ipsen
  • ISU ABXIS
  • Janssen
  • Jerini
  • JHL Biotech
  • Jiangsu Hengrui Medicine
  • Jiangsu T-Mab Biopharma
  • Johnson & Johnson
  • Jounce Therapeutics
  • kaleo
  • KaloBios Pharmaceuticals
  • Kiniksa Pharmaceuticals
  • Kissei Pharmaceutical
  • Kura Oncology
  • Kyowa Hakko Kirin
  • Labrys Biologics
  • Leadiant Biosciences
  • LEO Pharma
  • Levicept
  • Life Science Pharmaceuticals
  • MabVax Therapeutics
  • MacroGenics
  • Medical International Technology
  • MedImmune
  • Medipacs
  • MedPro Safety Products
  • Medtronic
  • Medtrum Technologies
  • Menarini Group
  • Merck
  • Merck Sharp & Dohme
  • Mereo BioPharma
  • Meridian Medical Technologies
  • Merrimack Pharmaceuticals
  • Mersana Therapeutics
  • Merus
  • Merz Pharma
  • Millennium Pharmaceuticals
  • MiNA Therapeutics
  • miRagen Therapeutics
  • Mitsubishi Tanabe Pharma
  • Moderna Therapeutics
  • Molecular Partners
  • Molecular Templates
  • MolMed
  • MorphoSys
  • Morphotek
  • MTD Micro Molding
  • Mylan
  • NantBioScience
  • Naurex
  • Navidea Biopharmaceuticals
  • Neogenix Oncology
  • Neon Therapeutics
  • NeuroDerm
  • Nordic Bioscience
  • Northern Biologics
  • Novartis Pharmaceuticals
  • Novimmune
  • NOVO Engineering
  • Novo Nordisk
  • OBI Pharma
  • Octapharma
  • Omeros
  • Oncology Venture
  • OncoMed Pharmaceuticals
  • OncoPep
  • Oncopeptides
  • Oncternal Therapeutics
  • Oncurious
  • Opthea
  • Optimer Pharmaceuticals
  • OSE Immunotherapeutics
  • Otsuka Pharmaceutical
  • Paion UK
  • Pfizer
  • PharmaJet
  • PharmaMar
  • PharmaSens
  • PhaseBio Pharmaceuticals
  • Phillips-Medisize
  • Philogen
  • Phosplatin Therapeutics
  • Pierre Fabre
  • Pique Therapeutics
  • Polaris Group
  • Polyphor
  • Prescient Therapeutics
  • Prestige BioPharma
  • Promedior
  • Prometheus Laboratories
  • Protalix Biotherapeutics
  • Proven Process Medical Devices
  • Quest PharmaTech
  • Quintessence Biosciences
  • R-Pharm
  • Ratio Drug Delivery
  • RAUMEDIC
  • Recro Pharma
  • Regeneron Pharmaceuticals
  • REMD Biotherapeutics
  • Resolve Therapeutics
  • rEVO Biologics
  • Rhythm Pharmaceuticals
  • Roche
  • Roehr pharmaceuticals
  • Sagentia
  • Samsung Bioepis
  • Sandoz
  • Sanofi
  • Santarus
  • Savient Pharmaceuticals
  • scPharmaceuticals
  • Seattle Genetics
  • Selecta Biosciences
  • Selexys Pharmaceuticals
  • Sensile Medical
  • Serina Therapeutics
  • Shire
  • SMC Global
  • Smiths Medical
  • Sonceboz
  • SOOIL
  • SteadyMed Therapeutics
  • Stealth BioTherapeutics
  • Stemline Therapeutics
  • Stevanato Group
  • Subcuject
  • Sumitomo Dainippon Pharma
  • Sunovion Pharmaceuticals
  • SymBio Pharmaceuticals
  • Symphogen
  • Synectics
  • Synermore Biologics
  • Syntimmune
  • Syros Pharmaceuticals
  • TaiMed Biologics
  • Taiwan Liposome Company
  • Takeda Pharmaceutical
  • Tandem Diabetes Care
  • Tanvex BioPharma
  • Tarveda Therapeutics
  • Teva Pharmaceutical
  • TG Therapeutics
  • Tolero Pharmaceuticals
  • TRACON Pharmaceuticals
  • Translational Sciences
  • Turnstone Biologics
  • United BioPharma
  • Vaccinex
  • Vaccinogen
  • Valtronic
  • vasopharm BIOTECH
  • Verily Life Sciences
  • Vetter Pharma
  • ViCentra
  • Viela Bio
  • ViiV Healthcare
  • Visterra
  • Vitaeris
  • Vivozon
  • Weibel CDS
  • West Pharmaceutical Services
  • Wockhardt
  • Xbiotech
  • Xencor
  • XOMA
  • Ypsomed
  • Zafgen
  • Zollner

For more information about this report visit https://www.researchandmarkets.com/research/r...olume?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Infusions and Injectables , Needles and Syringes

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 184

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 341

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 174

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 136

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 300

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
More News Articles

Top 5 Most Recently Viewed Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 558

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
ParaZero Technologies Achieves Nasdaq Compliance Milestone

Updated Category News Views 130

ParaZero Technologies Regains Compliance with Nasdaq Standards Recent developments in the aerospace sector have highlighted the impressive strides made by ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in safety systems for drones and urban air mobility vehicles. The company has reached a significant milestone, regaining compliance with Nasdaq’s minimum bid...

Continue Reading
Revolutionizing Semiconductor Design with AI Integration

Updated Category News Views 389

Ricursive Intelligence Launches Groundbreaking AI Lab Ricursive Intelligence is setting a new standard in semiconductor design with the introduction of its innovative AI lab. This initiative aims to seamlessly blend artificial intelligence with chip creation to expedite progress within the tech landscape. Major Funding and Valuation Boost The company recently raised an...

Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice

Updated Category News Views 219

Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...

Continue Reading
Stocks to Consider Amidst Global Market Uncertainty

Updated Category News Views 150

The Current Market Landscape As geopolitical tensions rise, markets are experiencing undercurrents of uncertainty. Recent tariff threats have sent ripples through global financial markets, particularly affecting investor confidence in stocks. The atmosphere is becoming increasingly cautious, with many investors wondering which stocks might shield their portfolios during...

Continue Reading